Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Vertex Pharmaceuticals Inc, Biogen Inc, Moderna Inc., AbbVie Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc and Incyte Corp.
2/7/2023 Health Care Sector Biotechnology Industry
$279,218
Change: -0.04%
Open: $278,146
High: $280,633
Low: $275,640
| Vertex Pharmaceuticals Inc (VRTX) |
+1.20%
|
| Biogen Inc (BIIB) |
+1.09%
|
| Moderna Inc. (MRNA) |
+0.46%
|
| AbbVie Inc (ABBV) |
+0.08%
|
| Amgen Inc (AMGN) |
+0.06%
|
| Biotechnology Industry |
-0.04%
|
| Gilead Sciences Inc (GILD) |
-0.36%
|
| Regeneron Pharmaceuticals Inc (REGN) |
-1.40%
|
| Incyte Corp (INCY) |
-4.03%
|
Index Value: $279,218 -0.04%
Volume: 7.34B Average Volume (3 month): 8.30B
Market Capitalization: $258.06T
EBITDA: $28.05T
PEG Ratio (5 year Expected): 0.77
Dividend Yield: 2.23%
Dividend Rate: $5,834
Dividend Yield (Forward): 2.37%
Dividend Rate (Forward): $6,210
Shares Outstanding: 1.84T
Book Value: $34,845
Short Ratio: 1.91
Price Target (1 year): $276,846
Volume: 7.34B Average Volume (3 month): 8.30B
Market Capitalization: $258.06T
EBITDA: $28.05T
PEG Ratio (5 year Expected): 0.77
Dividend Yield: 2.23%
Dividend Rate: $5,834
Dividend Yield (Forward): 2.37%
Dividend Rate (Forward): $6,210
Shares Outstanding: 1.84T
Book Value: $34,845
Short Ratio: 1.91
Price Target (1 year): $276,846
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| VRTX | Vertex Pharmaceuticals Inc | 308.54 | +1.20% | 1.14M | 0.79 | 10.13% |
| BIIB | Biogen Inc | 291.43 | +1.09% | 737,685 | 0.62 | 5.37% |
| MRNA | Moderna Inc. | 171.06 | +0.46% | 2.57M | 0.52 | 8.40% |
| ABBV | AbbVie Inc | 145.14 | +0.08% | 4.52M | 0.83 | 32.82% |
| AMGN | Amgen Inc | 244.00 | +0.06% | 2.31M | 0.84 | 16.65% |
| Biotechnology Industry | 279,218.23 | -0.04% | 7.34B | 0.88 | 12.90% | |
| GILD | Gilead Sciences Inc | 86.05 | -0.36% | 7.13M | 0.97 | 13.80% |
| REGN | Regeneron Pharmaceuticals Inc | 769.94 | -1.40% | 832,813 | 1.26 | 10.54% |
| INCY | Incyte Corp | 80.96 | -4.03% | 4.13M | 2.83 | 2.30% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| VRTX | Vertex Pharmaceuticals Inc | 78.257B | 2.56 | |
| BIIB | Biogen Inc | 41.513B | -4.54 | |
| MRNA | Moderna Inc. | 65.414B | -0.16 | |
| ABBV | AbbVie Inc | 256.465B | 3.88% | -3.61 |
| AMGN | Amgen Inc | 130.216B | 3.17% | 2.65 |
| Biotechnology Industry | $258.06T | 2.23% | 0.77 | |
| GILD | Gilead Sciences Inc | 107.691B | 3.46% | 4.92 |
| REGN | Regeneron Pharmaceuticals Inc | 85.037B | -1.12 | |
| INCY | Incyte Corp | 18.768B | 1.79 | |
Back to Market Summary